Emerging technologies and new directions in drug abuse research

Gespeichert in:
Bibliographische Detailangaben
Format: Buch
Sprache:English
Veröffentlicht: Rockville, MD 1991
Schriftenreihe:National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series 112
Schlagworte:
Online-Zugang:Inhaltsverzeichnis
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000 cb4500
001 BV005423366
003 DE-604
005 20030310
007 t|
008 920703s1991 xx ad|| |||| 00||| engod
020 |a 0160358515  |9 0-16-035851-5 
035 |a (OCoLC)24861441 
035 |a (DE-599)BVBBV005423366 
040 |a DE-604  |b ger  |e rakddb 
041 0 |a eng 
049 |a DE-12  |a DE-20 
050 0 |a RC566 
050 0 |a RM315 
082 0 |a 615/.78  |2 20 
084 |a CW 6940  |0 (DE-625)19200:  |2 rvk 
245 1 0 |a Emerging technologies and new directions in drug abuse research  |c eds.: Rao S. Rapaka ... 
264 1 |a Rockville, MD  |c 1991 
300 |a VII, 335 S.  |b Ill., graph. Darst. 
336 |b txt  |2 rdacontent 
337 |b n  |2 rdamedia 
338 |b nc  |2 rdacarrier 
490 1 |a National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series  |v 112 
650 2 |a Troubles liés à une substance 
650 4 |a Drug abuse  |x Treatment  |x Research  |z United States 
650 4 |a Narcotics 
650 4 |a Opioids  |x Receptors  |x Research  |z United States 
650 4 |a Psychopharmacology  |x Technological innovations  |z United States 
650 4 |a Psychotropic Drugs 
650 4 |a Receptors, Opioid 
650 4 |a Substance-Related Disorders  |x therapy 
650 4 |a Technology, Pharmaceutical 
650 0 7 |a Pharmazeutische Analyse  |0 (DE-588)4174139-0  |2 gnd  |9 rswk-swf 
650 0 7 |a Molekulardesign  |0 (DE-588)4265444-0  |2 gnd  |9 rswk-swf 
650 0 7 |a Halluzinogen  |0 (DE-588)4134941-6  |2 gnd  |9 rswk-swf 
651 4 |a USA 
655 7 |0 (DE-588)1071861417  |a Konferenzschrift  |2 gnd-content 
689 0 0 |a Halluzinogen  |0 (DE-588)4134941-6  |D s 
689 0 1 |a Pharmazeutische Analyse  |0 (DE-588)4174139-0  |D s 
689 0 |5 DE-604 
689 1 0 |a Halluzinogen  |0 (DE-588)4134941-6  |D s 
689 1 1 |a Molekulardesign  |0 (DE-588)4265444-0  |D s 
689 1 |5 DE-604 
700 1 |a Rapaka, Rao S.  |e Sonstige  |4 oth 
830 0 |a National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series  |v 112  |w (DE-604)BV001902214  |9 112 
856 4 2 |m GBV Datenaustausch  |q application/pdf  |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003390873&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA  |3 Inhaltsverzeichnis 
943 1 |a oai:aleph.bib-bvb.de:BVB01-003390873 

Datensatz im Suchindex

_version_ 1819656803123724288
adam_text EMERGING TECHNOLOGIES AND NEW DIRECTIONS IN DRUG ABUSE RESEARCH EDITORS: RAO S. RAPAKA, PH.D. ALEXANDROS MAKRIYANNIS, PH.D. MICHAEL J. KUHAR, PH.D. RESEARCH MONOGRAPH 112 1991 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE ALCOHOL, DRUG ABUSE, AND MENTAL, HEALTH ADMINISTRATION NATIONAL INSTITUTE ON DRUG ABUSE 5600 FISHERS LANE ROCKVILLE, MD 20857 CONTENTS PAGE FOREWORD III EMERGING TECHNOLOGIES AND NEW DIRECTIONS IN DRUG ABUSE RESEARCH: AN OVERVIEW 1 RAO S. RAPAKA, ALEXANDROS MAKRIYANNIS, AND MICHAEL J. KUHAR VORONOI BINDING SITE MODELS 7 GORDON M. CRIPPEN A MECHANISTIC BASIS FOR DESIGN OF SELECTIVE AGONISTS FOR 5-HT RECEPTORS 21 ROMAN OSMAN AND HAREL WEIOSTEIN COMPUTER-AIDED DRUG DESIGN FOR THE BENZODIAZEPINE RECEPTOR SITE 43 GILDA H. LOEW, HUGO O. VILLAR, WAYMONDJUNG, AND M. FRANCES DAVIES 3D-SEARCHING: AN OVERVIEW OF A NEW TECHNIQUE FOR COMPUTER-ASSISTED MOLECULAR DESIGN 62 ROBERT S. PEARLMAN PROTEIN STRUCTURE DETERMINATION IN SOLUTION USING NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY ..78 ANGELA M. GRONENBORN AND G. MARLUS CLORE COMBINED USE OF SOLID-STATE NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, SMALL-ANGLE X-RAY DIFFRACTION, AND DIFFERENTIAL SCANNING CALORIMETRY IN STUDIES OF CANNABINOID : MEMBRANE INTERACTIONS 106 ALEXANDROS MAKRIYANNIS, DE-PING YANG, AND THOMAS MAVROMOUSTAKOS CHARACTERIZATION AND LOCALIZATION OF CANNABINOID RECEPTORS IN BRAIN: AN IN VITRO TECHNIQUE USING SLIDE-MOUNTED TISSUE SECTIONS 129 MILES HERKENHAM NEW DEVELOPMENTS IN RADIOTRACERS FOR POSITRON EMISSION TOMOGRAPHY 146 JOANNA S. FOWLER AND ALFRED P. WOLF USE OF POSITRON EMISSION TOMOGRAPHY TO STUDY COCAINE IN THE HUMAN BRAIN 168 NORA D. VOLKOW, JOANNA S. FOWLER, AND ALFRED P. WOLF DEVELOPMENT OF OPIOID PEPTIDE ANALOGS AS PHARMACOLOGIC TOOLS AND AS POTENTIAL DRUGS: CURRENT STATUS AND FUTURE DIRECTIONS 180 PETER W.SCHILLER ~ CONFORMATIONAL ANALYSIS OF OPIOID RECEPTOR-SELECTIVE PEPTIDES USING NUCLEAR MAGNETIC RESONANCE AND THEORETICAL CALCULATIONS 198 VICTOR J. HRUBY, OM PRAKASH, WIESLAW KAZMIERSKI, CATHERINE GEHRIG, AND TERRY O. MATSUNAGA PEPTIDOMIMETIC OPIOIDS*SYNTHESIS, SPECTROSCOPY, AND COMPUTER SIMULATIONS 218 MURRAY GOODMAN, ODILE E. SAID-NEJAD, EDUARD FELDER, DALE F. MIERKE, TOSHIMASA YAMAZAKI, AND PETER W. SCHILLER MODIFIED SOLID-PHASE METHODS FOR THE RAPID SYNTHESIS OF OPIOID PEPTIDES : 239 RICHARD A. HOUGHTEN, JOHN M. OSTRESH, AND SUZANNE M. PRATT VI IRREVERSIBLE LIGANDS AS PROBES FOR DRUG RECEPTORS 256 AMY HAUCK NEWMAN IMPORTANT COMPOUNDS IN THE COCAINE CLASS: A SYNTHESIS OVERVIEW 284 F.I. CARROLL AND ANITA H. LEWIN IMMUNOMODULATORY EFFECTS OF DRUGS OF ABUSE AND THE IMPORTANCE OF STRUCTURE-LMMUNOMODULATORY ACTIVITY STUDIES 300 RAO S. RAPAKA AND CHARLES P. HOIBERG FDA REGULATORY REQUIREMENTS FOR INVESTIGATIONAL NEW DRUGS AND NEW DRUG APPLICATIONS: AN UPDATE 313 CHARLES P. HOIBERG AND RAO S. RAPAKA LIST OF NIDA RESEARCH MONOGRAPHS 326 VII
any_adam_object 1
building Verbundindex
bvnumber BV005423366
callnumber-first R - Medicine
callnumber-label RC566
callnumber-raw RC566
RM315
callnumber-search RC566
RM315
callnumber-sort RC 3566
callnumber-subject RC - Internal Medicine
classification_rvk CW 6940
ctrlnum (OCoLC)24861441
(DE-599)BVBBV005423366
dewey-full 615/.78
dewey-hundreds 600 - Technology (Applied sciences)
dewey-ones 615 - Pharmacology and therapeutics
dewey-raw 615/.78
dewey-search 615/.78
dewey-sort 3615 278
dewey-tens 610 - Medicine and health
discipline Psychologie
Medizin
format Book
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02330nam a2200577 cb4500</leader><controlfield tag="001">BV005423366</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20030310 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">920703s1991 xx ad|| |||| 00||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0160358515</subfield><subfield code="9">0-16-035851-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)24861441</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV005423366</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-20</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC566</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM315</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.78</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">CW 6940</subfield><subfield code="0">(DE-625)19200:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Emerging technologies and new directions in drug abuse research</subfield><subfield code="c">eds.: Rao S. Rapaka ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Rockville, MD</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VII, 335 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Institute on Drug Abuse &lt;Rockville, Md.&gt;: NIDA research monograph series</subfield><subfield code="v">112</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Troubles liés à une substance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug abuse</subfield><subfield code="x">Treatment</subfield><subfield code="x">Research</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Narcotics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Opioids</subfield><subfield code="x">Receptors</subfield><subfield code="x">Research</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychopharmacology</subfield><subfield code="x">Technological innovations</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychotropic Drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Receptors, Opioid</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Substance-Related Disorders</subfield><subfield code="x">therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Technology, Pharmaceutical</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Analyse</subfield><subfield code="0">(DE-588)4174139-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Molekulardesign</subfield><subfield code="0">(DE-588)4265444-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Halluzinogen</subfield><subfield code="0">(DE-588)4134941-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Halluzinogen</subfield><subfield code="0">(DE-588)4134941-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmazeutische Analyse</subfield><subfield code="0">(DE-588)4174139-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Halluzinogen</subfield><subfield code="0">(DE-588)4134941-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Molekulardesign</subfield><subfield code="0">(DE-588)4265444-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rapaka, Rao S.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Institute on Drug Abuse &lt;Rockville, Md.&gt;: NIDA research monograph series</subfield><subfield code="v">112</subfield><subfield code="w">(DE-604)BV001902214</subfield><subfield code="9">112</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&amp;doc_library=BVB01&amp;local_base=BVB01&amp;doc_number=003390873&amp;sequence=000001&amp;line_number=0001&amp;func_code=DB_RECORDS&amp;service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-003390873</subfield></datafield></record></collection>
genre (DE-588)1071861417 Konferenzschrift gnd-content
genre_facet Konferenzschrift
geographic USA
geographic_facet USA
id DE-604.BV005423366
illustrated Illustrated
indexdate 2024-12-23T11:36:47Z
institution BVB
isbn 0160358515
language English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-003390873
oclc_num 24861441
open_access_boolean
owner DE-12
DE-20
owner_facet DE-12
DE-20
physical VII, 335 S. Ill., graph. Darst.
publishDate 1991
publishDateSearch 1991
publishDateSort 1991
record_format marc
series National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series
series2 National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series
spellingShingle Emerging technologies and new directions in drug abuse research
National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series
Troubles liés à une substance
Drug abuse Treatment Research United States
Narcotics
Opioids Receptors Research United States
Psychopharmacology Technological innovations United States
Psychotropic Drugs
Receptors, Opioid
Substance-Related Disorders therapy
Technology, Pharmaceutical
Pharmazeutische Analyse (DE-588)4174139-0 gnd
Molekulardesign (DE-588)4265444-0 gnd
Halluzinogen (DE-588)4134941-6 gnd
subject_GND (DE-588)4174139-0
(DE-588)4265444-0
(DE-588)4134941-6
(DE-588)1071861417
title Emerging technologies and new directions in drug abuse research
title_auth Emerging technologies and new directions in drug abuse research
title_exact_search Emerging technologies and new directions in drug abuse research
title_full Emerging technologies and new directions in drug abuse research eds.: Rao S. Rapaka ...
title_fullStr Emerging technologies and new directions in drug abuse research eds.: Rao S. Rapaka ...
title_full_unstemmed Emerging technologies and new directions in drug abuse research eds.: Rao S. Rapaka ...
title_short Emerging technologies and new directions in drug abuse research
title_sort emerging technologies and new directions in drug abuse research
topic Troubles liés à une substance
Drug abuse Treatment Research United States
Narcotics
Opioids Receptors Research United States
Psychopharmacology Technological innovations United States
Psychotropic Drugs
Receptors, Opioid
Substance-Related Disorders therapy
Technology, Pharmaceutical
Pharmazeutische Analyse (DE-588)4174139-0 gnd
Molekulardesign (DE-588)4265444-0 gnd
Halluzinogen (DE-588)4134941-6 gnd
topic_facet Troubles liés à une substance
Drug abuse Treatment Research United States
Narcotics
Opioids Receptors Research United States
Psychopharmacology Technological innovations United States
Psychotropic Drugs
Receptors, Opioid
Substance-Related Disorders therapy
Technology, Pharmaceutical
Pharmazeutische Analyse
Molekulardesign
Halluzinogen
USA
Konferenzschrift
url http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003390873&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
volume_link (DE-604)BV001902214
work_keys_str_mv AT rapakaraos emergingtechnologiesandnewdirectionsindrugabuseresearch